BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21507037)

  • 1. EDNRB gene variants and melanoma risk in two southern European populations.
    Spica T; Fargnoli MC; Hetet G; Bertrand G; Formicone F; Descamps V; Wolkenstein P; Dupin N; Lebbe C; Basset-Seguin N; Saiag P; Cambien F; Grandchamp B; Peris K; Soufir N
    Clin Exp Dermatol; 2011 Oct; 36(7):782-7. PubMed ID: 21507037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
    Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
    Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of tyrosinase variants and skin cancer risk in a large cohort of French subjects.
    Hu HH; Guedj M; Descamps V; Jouary T; Bourillon A; Ezzedine K; Taieb A; Bagot M; Bensussan A; Saiag P; Grandchamp B; Basset-Seguin N; Soufir N
    J Dermatol Sci; 2011 Nov; 64(2):127-33. PubMed ID: 21906913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Brazil.
    Bakos RM; Besch R; Zoratto GG; Godinho JM; Mazzotti NG; Ruzicka T; Bakos L; Santos SE; Ashton-Prolla P; Berking C; Giugliani R
    Exp Dermatol; 2011 Nov; 20(11):890-3. PubMed ID: 21895773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDKN2A common variants and their association with melanoma risk: a population-based study.
    Debniak T; Scott RJ; Huzarski T; Byrski T; Rozmiarek A; Debniak B; Załuga E; Maleszka R; Kładny J; Górski B; Cybulski C; Gronwald J; Kurzawski G; Lubinski J
    Cancer Res; 2005 Feb; 65(3):835-9. PubMed ID: 15705881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2A mutations in melanoma families from Uruguay.
    Larre Borges A; Cuéllar F; Puig-Butillé JA; Scarone M; Delgado L; Badenas C; Milà M; Malvehy J; Barquet V; Núñez J; Laporte M; Fernández G; Levrero P; Martínez-Asuaga M; Puig S
    Br J Dermatol; 2009 Sep; 161(3):536-41. PubMed ID: 19523171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
    Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M
    BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDKN2A mutations in multiple primary melanomas.
    Monzon J; Liu L; Brill H; Goldstein AM; Tucker MA; From L; McLaughlin J; Hogg D; Lassam NJ
    N Engl J Med; 1998 Mar; 338(13):879-87. PubMed ID: 9516223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
    Begg CB; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Mitra N; Busam K; From L; Berwick M;
    J Natl Cancer Inst; 2005 Oct; 97(20):1507-15. PubMed ID: 16234564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma.
    Luongo V; Pirozzi G; Caracò C; Errico S; de Angelis F; Celentano E; Paino F; Chiofalo MG; Luongo M; Mozzillo N; Lombardi ML
    Tissue Antigens; 2004 Jul; 64(1):84-7. PubMed ID: 15191529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families.
    Mantelli M; Barile M; Ciotti P; Ghiorzo P; Lantieri F; Pastorino L; Catricalà C; Torre GD; Folco U; Grammatico P; Padovani L; Pasini B; Rovini D; Queirolo P; Rainero ML; Santi PL; Sertoli RM; Goldstein AM; Bianchi-Scarrà G; ;
    Am J Med Genet; 2002 Jan; 107(3):214-21. PubMed ID: 11807902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
    Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the CDKN2A locus in patients with multiple primary melanomas.
    Puig S; Malvehy J; Badenas C; Ruiz A; Jimenez D; Cuellar F; Azon A; Gonzàlez U; Castel T; Campoy A; Herrero J; Martí R; Brunet-Vidal J; Milà M
    J Clin Oncol; 2005 May; 23(13):3043-51. PubMed ID: 15860862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variations of patients with familial or multiple melanoma in Southern Brazil.
    Grazziotin TC; Rey MC; Bica CG; Pinto LA; Bonamigo RR; Puig-Butille JA; Cuellar F; Puig S
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e179-85. PubMed ID: 22621339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of endothelin-beta receptor (EDNRB) gene variants in anorectal malformations.
    Moore SW; Zaahl MG
    J Pediatr Surg; 2007 Jul; 42(7):1266-70. PubMed ID: 17618893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p.G23S CDKN2A founder mutation in high-risk melanoma families from Central Italy.
    Gensini F; Sestini R; Piazzini M; Vignoli M; Chiarugi A; Brandani P; Ghiorzo P; Salvini C; Borgognoni L; Palli D; Bianchi-Scarrà G; Carli P; Genuardi M
    Melanoma Res; 2007 Dec; 17(6):387-92. PubMed ID: 17992122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.
    Nagore E; Montoro A; García-Casado Z; Botella-Estrada R; Insa A; Lluch A; López-Guerrero JA; Guillén C
    Melanoma Res; 2009 Aug; 19(4):211-4. PubMed ID: 19571771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and recurrent p14 mutations in Italian familial melanoma.
    Binni F; Antigoni I; De Simone P; Majore S; Silipo V; Crisi A; Amantea A; Pacchiarini D; Castori M; De Bernardo C; Catricalà C; Grammatico P
    Clin Genet; 2010 Jun; 77(6):581-6. PubMed ID: 20132244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A French CDK4-positive melanoma family with a co-inherited EDNRB mutation.
    Soufir N; Ollivaud L; Bertrand G; Lacapère JJ; Descamps V; Vitoux D; Lebbe C; Wolkenstein P; Dupin N; Saiag P; Basset-Seguin N; Grandchamp B;
    J Dermatol Sci; 2007 Apr; 46(1):61-4. PubMed ID: 17223014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.